Mylan receives FDA approval for generic Hyzaar, Wellbutrin SR

04/12/2010 | American City Business Journals

Mylan gained FDA approval to market generic formulations of Merck & Co.'s blood pressure drug Hyzaar and GlaxoSmithKline's antidepressant Wellbutrin SR. The generic-drug firm has started shipping the products, known as losartan potassium and hydrochlorothiazide tablets and bupropion hydrochloride extended-release tablets, respectively.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN